The Dutch ZonMW has awarded EUR 750,000 to a research project into the exact role of LRRK2 in the development of Parkinson's disease. Prof. Arjan Kortholt (GBB) and
Prof. Amalia Dolga (GRIP) of the University of Groningen, and Prof. Erik Boddeke of the University Medical Center Groningen have combined their expertise in this study.
An emerging hypothesis in Parkinson’s disease points towards a critical role of inflammation and cell metabolism in specific brain cells such as microglia and neurons. Leucine-rich repeat kinase 2 (LRRK2) is considered as an essential player in PD pathogenesis, however the exact role of LRRK2 in immune cells is still not well understood.
In their research project, ‘How LRRK2 affect neuron-microglia communication in Parkinson’s disease’, Dolga, Kortholt and Boddeke are joining forces and their expertise. They will characterize the complex activation mechanism, localization and function of LRRK2 in immunity and cell metabolism in Parkinson’s Disease. They will develop and use a set of unique tools to get detailed insight in the function of LRRK2 in iPSC-derived brain cells (microglia and neurons). This innovative science will expand the understanding of Parkinson’s Disease’s pathology, will generate the proof of principle of novel compound targeting LRRK2 and will provide a novel model for testing future therapies.
Yesterday, a team of RUG students won the European Rover Challenge in Poland, a three-day competition in which student teams from all over the world compete.
BirdEyes is the Centre for Global and Ecological Change initiated by, among other partners, FSE and Campus Fryslân
Billerbeck, researcher at the Groningen Biomolecular Sciences and Biotechnology Institute (GBB), receives about 1.5 million for her part in the project.
The UG website uses functional and anonymous analytics cookies. Please answer the question of whether you want to accept
or reject other cookies (such as tracking cookies).
If no choice is made, only basic cookies will be stored. More information